Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

The Big Picture: SPARX takes on resurgence of Japanese equity

Thursday, October 17, 2013

amb
Shuhei Abe
Benedicte Gravrand, Opalesque Geneva:

An Opalesque column for global macro investors.

Shuhei Abe, the founder of SPARX Asset Management, Asia's largest hedge fund manager based in Tokyo, says he has been very bullish since the beginning of this year, as Japan looks like it is ending its long-term deflationary super-cycle.

Coming out of a bubble The cycle started with the Japanese asset price bubble, an economic bubble in the late 80-early 90s in which real estate and stock prices were greatly inflated. The aftermath of that bubble saw asset prices continuing to fall, leading to what was called the "lost decade". The Nikkei 225 started plummeting in December 1989 from a high of almost 40,000 to lose 64% of its value in 32 months. Although showing many ups and down during the next few years, it never got back to this peak and lost a total of 82% from that day till October 2008. After that, the index was kept down by the financial crisis, the March 2011 earthquake and other events. But Shinzo Abe came to power, and the index climbed up again in December 2012.

"In 2010, I felt a bit positive on the market, but unfortunately, my optimism was not supported by reality," said SPARX' Shuhei Abe. "We had the Tohoku earthquake and the nuclear plant meltdown, and that year through to the beginning of 2012, we ha......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its